Makers Lab Peer Comparison

BSE: 506919

₹219.44

₹4.34 (2.02%)

As on 05-Nov-2026IST

Market cap

₹131 Cr

Revenue (TTM)

₹162 Cr

P/E Ratio

17.5

P/B Ratio

1.7

Div. Yield

0 %

Edit

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Market cap (₹ Cr)	131	17,993	17,641	17,064	14,568
Revenue (₹ Cr)	162	1,842	2,654	3,330	1,559
Net Profit (₹ Cr)	18.95	308.62	859.38	720.77	206.58
Net Margin (%)	11.50	16.63	30.42	21.60	13.15
RoE (%)	9.89	11.81	18.58	18.93	28.52
Price to Earnings	17.53	54.12	20.53	24.12	70.37
Price-To-Book	1.68	6.70	4.02	4.12	18.09

Income Statement (₹ Cr)

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Operating Revenue	162.40	1,841.62	2,654.29	3,329.63	1,559.11
Total Income	164.85	1,855.87	2,825.39	3,337.47	1,571.09
Total Expenditure	133.90	1,328.95	1,681.39	2,168.88	1,224.85
EBITDA	28.51	512.67	972.90	1,160.75	334.26
Depreciation	4.56	130.47	57.71	285.40	48.04
EBIT	23.95	382.20	915.19	875.35	286.22
Interest	0.67	49.12	8.91	187.51	8.48
Other Income	2.44	14.25	171.10	7.84	11.98
Exceptional Items	0.00	11.73	82.90	-53.14	-19.10
Profit before Tax	25.72	359.06	1,160.28	642.54	270.62
Provision for Tax	6.77	50.44	300.90	-78.23	64.04
Profit after Tax	18.95	308.62	859.38	720.77	206.58

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Shareholder's Funds	78.35	2,757.68	4,385.41	4,144.34	804.07
Minority Interest	-11.47	0.00	0.00	-10.85	0.00
Non-Current Liabilities	8.93	363.37	222.21	758.48	108.63
Current Liabilities	37.88	1,016.50	685.36	2,681.14	333.00
Total Liabilities	166.62	3,705.61	4,921.88	7,246.72	--

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Non-Current Assets	72.33	2,763.86	905.21	5,578.78	719.39
Current Assets	102.88	1,277.15	4,024.56	1,800.86	473.68
Total Assets	166.62	3,705.61	4,921.88	7,246.72	--
Total Debt*	4.76	657.97	2.50	2,309.68	--
Net Current Assets	65.00	260.65	3,339.20	-880.28	140.68
Contingent Liabilities	4.71	160.01	370.49	51.57	--

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Cash From Operating Activities	14.29	342.18	967.57	537.99	--
Cash Flow from Investing Activities	-14.69	-325.92	-561.67	-369.46	--
Cash from Financing Activities	0.35	13.62	-798.31	-313.53	--
Net Cash Inflow / Outflow	-0.05	29.88	-392.41	-145.00	--

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
ROCE (%)	15.83	11.43	23.39	14.47	--
ROE (%)	9.89	11.81	18.58	18.93	28.50
ROA (%)	11.20	8.09	17.36	9.78	18.60
EBIT Margin (%)	14.74	20.75	34.48	26.29	18.36
Net Margin (%)	11.50	16.63	30.42	21.60	13.15
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Revenue Growth (%)	24.19	37.26	11.75	11.06	20.02
EBIT Growth (%)	358.28	56.89	21.45	13.71	22.30
Net Profit Growth (%)	387.90	127.86	2.39	60.98	18.28
EPS Growth (%)	30,791.92	5.65	13.17	80.38	26.45
Book Value Growth (%)	3.43	9.67	-0.34	36.71	--

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Price / Earnings	17.54	56.99	22.11	22.33	65.96
Price / Book Value	1.68	6.70	4.02	4.12	18.12
Dividend Yield (%)	0.00	0.07	1.94	0.00	0.42
EV/EBITDA	4.34	36.29	14.94	16.63	43.88
Market Cap (₹ Cr)	79.77	6,819.66	21,592.90	17,980.08	--

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Debt to Equity	0.00	0.08	0.00	0.10	0.00
Short term debt to equity ratio	0.04	0.16	0.00	0.12	--
Current Ratio	2.72	1.26	5.87	0.67	1.42
Quick Ratio	1.38	0.82	5.23	0.49	0.91
Interest Coverage	39.62	8.31	131.22	4.43	32.91

	Makers Lab	Shilpa Medicare	Pfizer	Eris Lifesciences	CORONA Remedies
Debtors to sales (%)	13.46	29.09	9.10	18.98	10.94
Asset Turnover	0.96	0.48	0.54	0.45	1.40
Receivable days	62.18	113.81	26.06	63.88	--
Inventory Days	102.52	84.76	65.95	43.27	--
Payable days	90.08	101.94	81.01	151.85	--
Cash Conversion Cycle	74.62	96.62	11.00	-44.70	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.